Page 100 - VHSA - Onderstepoort 100 Years - Part 3

OND
ERSTEPOORT 100
OBP’s total income rose from R48.9 million in 2002 to a maximum of R76.1 million in 2005 and decreased to R72.1 million in 2006. This was mainly due to a decrease from 105 million to 90 million doses of vaccine sold because of decreased export volumes.
Compared with the 143.04 million doses of 1983, there is clearly a considerable decrease in sales. This can probably be ascribed to decreased local use of OBP vaccines for reasons
already mentioned. On the other hand, the Vaccine Factory’s total income in 1983 was only R 4.7 million. OBP’s current share in the local livestock vaccines market is said to be approximately 48%.
L. Makuleni resigned from OBP in 2007 when she was appointed Chief Executive Officer of the South African Weather Service. She was replaced by V. Penxa as Managing Director in the same year.
The current main entrance to Onderstepoort Biological Products
190
OBP BOARD & EXCO MEMBERS (FEBRUARY 2008)
Back row (left to right): Ms L. Bonga (Company Secretary), Mr P.M. Pieterson (Project Management Executive),
Mr M. Dada (Acting Chief Financial Officer), Dr B. Dungu (Chief Scientific Officer),
Ms S. Burger (Shared Services Executive), Mr W.J.S. Botha (Sales and Marketing Executive)
Front row (left to right): Mr S.S.M. Seane, (Board Member) Ms N. Qata, (Board Member) Ms N.D. Shabalala (Chairperson), Ms V. Penxa (Managing Director), Ms N. Jaxa, (Board Member), Adv D.J. Mitchell (Board Member)
PART 3
History of Individual Disciplines
1908-2008
Years